Table of Content
Table of Contents
Global Multivalent Vaccines Market Report 2024, Forecast to 2031
1 Scope of the Study
1.1 Multivalent Vaccines Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Multivalent Vaccines Industry Overview
2.1 Global Multivalent Vaccines Market Size (Million USD) Comparison by Regions (2024-2031)
2.1.1 Multivalent Vaccines Global Import Market Analysis
2.1.2 Multivalent Vaccines Global Export Market Analysis
2.1.3 Multivalent Vaccines Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Conjugate Vaccines
2.2.2 Inactivated and Subunit Vaccines
2.2.3 Live Attenuated Vaccines
2.2.4 Toxoid Vaccines
2.2.5 Recombinant Vaccines
2.3 Market Analysis by Application
2.3.1 Pediatrics
2.3.2 Adults
2.4 Global Multivalent Vaccines Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Multivalent Vaccines Sales and Market Share by Manufacturer (2019-2023)
2.4.2 Global Multivalent Vaccines Revenue and Market Share by Manufacturer (2019-2023)
2.4.3 Global Multivalent Vaccines Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Multivalent Vaccines Manufacturer Market Share
2.4.5 Top 10 Multivalent Vaccines Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Multivalent Vaccines Market
2.4.7 Key Manufacturers Multivalent Vaccines Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Multivalent Vaccines Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Multivalent Vaccines Industry Impact
2.7.1 How the Covid-19 is Affecting the Multivalent Vaccines Industry
2.7.2 Multivalent Vaccines Business Impact Assessment - Covid-19
2.7.3 Market Trends and Multivalent Vaccines Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Multivalent Vaccines Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Multivalent Vaccines Market Size Categorized by Regions
4.1 Global Multivalent Vaccines Revenue, Sales and Market Share by Regions
4.1.1 Global Multivalent Vaccines Sales and Market Share by Regions (2019-2023)
4.1.2 Global Multivalent Vaccines Revenue and Market Share by Regions (2019-2023)
4.2 Europe Multivalent Vaccines Sales and Growth Rate (2019-2023)
4.3 APAC Multivalent Vaccines Sales and Growth Rate (2019-2023)
4.4 North America Multivalent Vaccines Sales and Growth Rate (2019-2023)
4.5 South America Multivalent Vaccines Sales and Growth Rate (2019-2023)
4.6 Middle East & Africa Multivalent Vaccines Sales and Growth Rate (2019-2023)
5 Europe Multivalent Vaccines Market Size Categorized by Countries
5.1 Europe Multivalent Vaccines Sales, Revenue and Market Share by Countries
5.1.1 Europe Multivalent Vaccines Sales by Countries (2019-2023)
5.1.2 Europe Multivalent Vaccines Revenue by Countries (2019-2023)
5.1.3 Germany Multivalent Vaccines Sales and Growth Rate (2019-2023)
5.1.4 UK Multivalent Vaccines Sales and Growth Rate (2019-2023)
5.1.5 France Multivalent Vaccines Sales and Growth Rate (2019-2023)
5.1.6 Russia Multivalent Vaccines Sales and Growth Rate (2019-2023)
5.1.7 Italy Multivalent Vaccines Sales and Growth Rate (2019-2023)
5.1.8 Spain Multivalent Vaccines Sales and Growth Rate (2019-2023)
5.2 Europe Multivalent Vaccines Revenue (Value) by Manufacturers (2019-2023)
5.3 Europe Multivalent Vaccines Sales, Revenue and Market Share by Type (2019-2023)
5.3.1 Europe Multivalent Vaccines Sales Market Share by Type (2019-2023)
5.3.2 Europe Multivalent Vaccines Revenue and Revenue Share by Type (2019-2023)
5.4 Europe Multivalent Vaccines Sales Market Share by Application (2019-2023)
6 Asia-Pacific Multivalent Vaccines Market Size Categorized by Countries
6.1 Asia-Pacific Multivalent Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Multivalent Vaccines Sales by Countries (2019-2023)
6.1.2 Asia-Pacific Multivalent Vaccines Revenue by Countries (2019-2023)
6.1.3 China Multivalent Vaccines Sales and Growth Rate (2019-2023)
6.1.4 Japan Multivalent Vaccines Sales and Growth Rate (2019-2023)
6.1.5 Korea Multivalent Vaccines Sales and Growth Rate (2019-2023)
6.1.6 India Multivalent Vaccines Sales and Growth Rate (2019-2023)
6.1.7 Southeast Asia Multivalent Vaccines Sales and Growth Rate (2019-2023)
6.1.8 Australia Multivalent Vaccines Sales and Growth Rate (2019-2023)
6.2 Asia-Pacific Multivalent Vaccines Sales and Revenue (Value) by Manufacturers (2019-2023)
6.3 Asia-Pacific Multivalent Vaccines Sales, Revenue and Market Share by Type (2019-2023)
6.3.1 Asia-Pacific Multivalent Vaccines Sales Market Share by Type (2019-2023)
6.3.2 Asia-Pacific Multivalent Vaccines Revenue and Revenue Share by Type (2019-2023)
6.4 Asia-Pacific Multivalent Vaccines Sales and Market Share by Application (2019-2023)
7 North America Multivalent Vaccines Market Size Categorized by Countries
7.1 North America Multivalent Vaccines Sales, Revenue and Market Share by Countries
7.1.1 North America Multivalent Vaccines Sales by Countries (2019-2023)
7.1.2 North America Multivalent Vaccines Revenue by Countries (2019-2023)
7.1.3 United States Multivalent Vaccines Sales and Growth Rate (2019-2023)
7.1.4 Canada Multivalent Vaccines Sales and Growth Rate (2019-2023)
7.1.5 Mexico Multivalent Vaccines Sales and Growth Rate (2019-2023)
7.2 North America Multivalent Vaccines Revenue (Value) by Manufacturers (2019-2023)
7.3 North America Multivalent Vaccines Sales, Revenue and Market Share by Type (2019-2023)
7.3.1 North America Multivalent Vaccines Sales Market Share by Type (2019-2023)
7.3.2 North America Multivalent Vaccines Revenue and Revenue Share by Type (2019-2023)
7.4 North America Multivalent Vaccines Sales Market Share by Application (2019-2023)
8 South America Multivalent Vaccines Market Size Categorized by Countries
8.1 South America Multivalent Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Multivalent Vaccines Sales by Countries (2019-2023)
8.1.2 South America Multivalent Vaccines Revenue by Countries (2019-2023)
8.1.3 Brazil Multivalent Vaccines Sales and Growth Rate (2019-2023)
8.2 South America Multivalent Vaccines Revenue (Value) by Manufacturers (2019-2023)
8.3 South America Multivalent Vaccines Sales, Revenue and Market Share by Type (2019-2023)
8.3.1 South America Multivalent Vaccines Sales Market Share by Type (2019-2023)
8.3.2 South America Multivalent Vaccines Revenue and Revenue Share by Type (2019-2023)
8.4 South America Multivalent Vaccines Sales Market Share by Application (2019-2023)
9 Middle East and Africa Multivalent Vaccines Market Size Categorized by Countries
9.1 Middle East and Africa Multivalent Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Multivalent Vaccines Sales by Countries (2019-2023)
9.1.2 Middle East and Africa Multivalent Vaccines Revenue by Countries (2019-2023)
9.1.3 GCC Countries Multivalent Vaccines Sales and Growth Rate (2019-2023)
9.1.4 Turkey Multivalent Vaccines Sales and Growth Rate (2019-2023)
9.1.5 Egypt Multivalent Vaccines Sales and Growth Rate (2019-2023)
9.1.6 South Africa Multivalent Vaccines Sales and Growth Rate (2019-2023)
9.2 Middle East and Africa Multivalent Vaccines Revenue (Value) by Manufacturers (2019-2023)
9.3 Middle East and Africa Multivalent Vaccines Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Multivalent Vaccines Sales Market Share by Type (2019-2023)
9.3.2 Middle East and Africa Multivalent Vaccines Revenue and Revenue Share by Type (2019-2023)
9.4 Middle East and Africa Multivalent Vaccines Sales Market Share by Application (2019-2023)
10 Global Multivalent Vaccines Market Segment by Type
10.1 Global Multivalent Vaccines Revenue, Sales and Market Share by Type (2019-2023)
10.1.1 Global Multivalent Vaccines Sales and Market Share by Type (2019-2023)
10.1.2 Global Multivalent Vaccines Revenue and Market Share by Type (2019-2023)
10.2 Conjugate Vaccines Sales Growth Rate and Price
10.2.1 Global Conjugate Vaccines Sales Growth Rate (2019-2023)
10.2.2 Global Conjugate Vaccines Price (2019-2023)
10.3 Inactivated and Subunit Vaccines Sales Growth Rate and Price
10.3.1 Global Inactivated and Subunit Vaccines Sales Growth Rate (2019-2023)
10.3.2 Global Inactivated and Subunit Vaccines Price (2019-2023)
10.4 Live Attenuated Vaccines Sales Growth Rate and Price
10.4.1 Global Live Attenuated Vaccines Sales Growth Rate (2019-2023)
10.4.2 Global Live Attenuated Vaccines Price (2019-2023)
10.5 Toxoid Vaccines Sales Growth Rate and Price
10.5.1 Global Toxoid Vaccines Sales Growth Rate (2019-2023)
10.5.2 Global Toxoid Vaccines Price (2019-2023)
10.6 Recombinant Vaccines Sales Growth Rate and Price
10.6.1 Global Recombinant Vaccines Sales Growth Rate (2019-2023)
10.6.2 Global Recombinant Vaccines Price (2019-2023)
11 Global Multivalent Vaccines Market Segment by Application
11.1 Global Multivalent VaccinesSales Market Share by Application (2019-2023)
11.2 Pediatrics Sales Growth Rate (2019-2023)
11.3 Adults Sales Growth Rate (2019-2023)
12 Market Forecast for Multivalent Vaccines
12.1 Global Multivalent Vaccines Revenue, Sales and Growth Rate (2024-2031)
12.2 Multivalent Vaccines Market Forecast by Regions (2024-2031)
12.2.1 Europe Multivalent Vaccines Market Forecast (2024-2031)
12.2.2 APAC Multivalent Vaccines Market Forecast (2024-2031)
12.2.3 North America Multivalent Vaccines Market Forecast (2024-2031)
12.2.4 South America Multivalent Vaccines Market Forecast (2024-2031)
12.2.5 Middle East & Africa Multivalent Vaccines Market Forecast (2024-2031)
12.3 Multivalent Vaccines Market Forecast by Type (2024-2031)
12.3.1 Global Multivalent Vaccines Sales Forecast by Type (2024-2031)
12.3.2 Global Multivalent Vaccines Market Share Forecast by Type (2024-2031)
12.4 Multivalent Vaccines Market Forecast by Application (2024-2031)
12.4.1 Global Multivalent Vaccines Sales Forecast by Application (2024-2031)
12.4.2 Global Multivalent Vaccines Market Share Forecast by Application (2024-2031)
13 Analysis of Multivalent Vaccines Industry Key Manufacturers
13.1 GlaxoSmithKline, plc .
13.1.1 Company Details
13.1.2 Product Information
13.1.3 GlaxoSmithKline, plc . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.1.4 Main Business Overview
13.1.5 GlaxoSmithKline, plc . News
13.2 Pfizer, Inc. .
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Pfizer, Inc. . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.2.4 Main Business Overview
13.2.5 Pfizer, Inc. . News
13.3 Merck & Co., Inc. .
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Merck & Co., Inc. . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.3.4 Main Business Overview
13.3.5 Merck & Co., Inc. . News
13.4 Sanofi Pasteur SA .
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Sanofi Pasteur SA . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.4.4 Main Business Overview
13.4.5 Sanofi Pasteur SA . News
13.5 Astellas Pharma Inc. .
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Astellas Pharma Inc. . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.5.4 Main Business Overview
13.5.5 Astellas Pharma Inc. . News
13.6 CSL Limited (Australia)
13.6.1 Company Details
13.6.2 Product Information
13.6.3 CSL Limited (Australia) Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.6.4 Main Business Overview
13.6.5 CSL Limited (Australia) News
13.7 Emergent BioSolutions, Inc. .
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Emergent BioSolutions, Inc. . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.7.4 Main Business Overview
13.7.5 Emergent BioSolutions, Inc. . News
13.8 Johnson & Johnson .
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Johnson & Johnson . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.8.4 Main Business Overview
13.8.5 Johnson & Johnson . News
13.9 MedImmune, LLC .
13.9.1 Company Details
13.9.2 Product Information
13.9.3 MedImmune, LLC . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.9.4 Main Business Overview
13.9.5 MedImmune, LLC . News
13.10 Serum Institute of India Pvt. Ltd. .
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Serum Institute of India Pvt. Ltd. . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.10.4 Main Business Overview
13.10.5 Serum Institute of India Pvt. Ltd. . News
13.11 Bavarian Nordic .
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Bavarian Nordic . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.11.4 Main Business Overview
13.11.5 Bavarian Nordic . News
13.12 Mitsubishi Tanabe Pharma Corporation .
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Mitsubishi Tanabe Pharma Corporation . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.12.4 Main Business Overview
13.12.5 Mitsubishi Tanabe Pharma Corporation . News
13.13 Daiichi Sankyo .
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Daiichi Sankyo . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.13.4 Main Business Overview
13.13.5 Daiichi Sankyo . News
13.14 Protein Sciences Corporation .
13.14.1 Company Details
13.14.2 Product Information
13.14.3 Protein Sciences Corporation . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.14.4 Main Business Overview
13.14.5 Protein Sciences Corporation . News
13.15 Panacea Biotec .
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Panacea Biotec . Multivalent Vaccines Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
13.15.4 Main Business Overview
13.15.5 Panacea Biotec . News
14 Research Findings and Conclusion
15 Appendix